|
Supplier News Breaks Archives Sanofi-aventis and the Juvenile Diabetes Research Foundation (JDRF) are partnering to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease, as well as to prevent diabetes in those at risk. AstraZeneca has launched a patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed Arimidex. Scott Verner has been appointed president at Nipro Diagnostics Inc., which was formed last month with the merger of Home Diagnostics Inc. and Nipro Diabetes Systems. Walgreen Co. this week plans to roll out what it calls a "hot" and "must-have" toy on store shelves nationwide. Procter & Gamble Co.'s Pepto-Bismol brand has been named as the first-ever stomach remedy sponsor of the annual Nathan's Famous Fourth of July Hot Dog Eating Contest. Mylan Pharmaceuticals Inc., Breckenridge Pharmaceutical Inc. and APP Pharmaceuticals have received approval from the Food and Drug Administration to offer anastrozole tablets, a treatment for early breast cancer. LifeScan Inc. has rolled out the OneTouch Delica Lancing System, which sports a thinner lancet, more depth settings and an advanced lancing control to provide more comfortable blood glucose testing for diabetes patients. PepsiCo's Frito-Lay North America business unit has introduced two new varieties of Lightly Salted chips. Procter & Gamble Co.'s Crest Pro-Health Sensitive Shield toothpaste brand has kicked off its "Summer of Sensitivity" campaign in New York City's Penn Station transit hub in partnership with television celebrity Alison Sweeney and hunger relief charity Feeding America. Pharmacy technology providers PDX and mscripts have launched an integrated solution that enables PDX Pharmacy System users to connect with patients through a variety of mobile communication pathways using the mscripts platform.
|
